Finzati - Logo
XTNT logo

Xtant Medical Holdings, Inc.

XTNT • Medical - Devices
$0.38
▼ -0.02 (-5.21%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$43.76M
Growth
-3.9%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 10.4%Positive free cash flow · 0.07Reasonable earnings multiple · 22Manageable debt level · 0.56Healthy liquidity · 2.65
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:04 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.38
Change-5.21%
Market Cap$43.76M
52W Range0.27 - 0.95
Beta-0.14
Dividend Yield0.00%
Gross Margin62.92%
Oper. Margin5.44%
Profit Margin3.71%
Debt/Eq0.56
Current Ratio2.65
Quick Ratio1.63

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
42/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Positive revenue growth · 10.4%Positive free cash flow · 0.07Reasonable earnings multiple · 22Manageable debt level · 0.56Healthy liquidity · 2.65

Analyst view

Analyst sentiment and price target

XTNT
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
90/100
Bullish
Bullish
4
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$1.50
Mean
$1.50
Median
$1.50
High
$1.50

Company Overview

IPO: 7/1/2010
Industry: Medical - Devices
P/B i: 2.15
Debt / Equity i: 0.56
Operating Margin: 5.44%
Net Margin: 3.71%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.56
Current Ratio: 2.65
Quick Ratio: 1.63
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Schallenberger Mark A.
Transaction: 02/15/2026
SELL
Change
-7,709
Price
$0.58
Filing
02/18/2026
Type
SELL
Neils Scott C
Transaction: 01/15/2026
SELL
Change
-8,084
Price
$0.65
Filing
01/16/2026
Type
SELL
Neils Scott C
Transaction: 11/15/2025
BUY
Change
+526,582
Price
Not reported
Filing
11/18/2025
Type
BUY